Page last updated: 2024-12-05
tripropionin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
tripropionin : A triglyceride obtained by formal acylation of the three hydroxy groups of glycerol by propionic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 8763 |
| CHEBI ID | 88153 |
| SCHEMBL ID | 76782 |
| MeSH ID | M0099211 |
Synonyms (58)
| Synonym |
|---|
| wln: 2vo1yov2 & 1ov2 |
| 139-45-7 |
| tripropionin |
| nsc36744 |
| nsc-36744 |
| glyceryl tripropionate |
| 1,3-propanetriol, tripropanoate |
| glycerine tripropionate |
| tripropionine |
| propionin, tri- |
| glycerol tripropionate |
| 1,2,3-propanetriol, tripropanoate |
| tripropionin, >=97.1%, fcc, fg |
| brn 1713645 |
| nsc 36744 |
| einecs 205-365-1 |
| glyceryl tripropanoate |
| tripropionylglycerol |
| fema no. 3286 |
| propionic acid triglyceride |
| ai3-07939 |
| 2,3-di(propanoyloxy)propyl propanoate |
| G0090 |
| f8l8evq6qb , |
| unii-f8l8evq6qb |
| 4-02-00-00717 (beilstein handbook reference) |
| 1,2,3-propanetriol, 1,2,3-tripropanoate |
| FT-0626750 |
| AKOS015912947 |
| SCHEMBL76782 |
| glyceryl tripropanoate [fhfi] |
| glyceryl tripropanoate [fcc] |
| 2,3-bis(propionyloxy)propyl propionate # |
| 1,2,3-propanetriol, tripropionate |
| DTXSID8051702 |
| W-108214 |
| 1,2,3-propanetriol tripropanoate |
| CHEBI:88153 |
| 1,2,3-tripropanoylglycerol |
| propane-1,2,3-triyl tripropanoate |
| propane-1,2,3-triyl tripropionate |
| tripropionin, analytical standard |
| mfcd00027005 |
| AS-61403 |
| 1,3-bis(propanoyloxy)propan-2-yl propanoate |
| tripropionin, >=95% |
| 1,2,3-propanetriol tripropanoate, 9ci |
| 2,3-bis(propionyloxy)propyl propionate |
| fema 3286 |
| tri-propionin |
| tripropionin, 8ci |
| glycerol tripropanoate |
| propionin, tri- (8ci) |
| Q27160090 |
| 1,2,3-tris-propionyloxy-propane |
| D95972 |
| propane-1,2,3-triyltripropionate |
| CS-0320953 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Roles (1)
| Role | Description |
|---|---|
| flavouring agent | A food additive that is used to added improve the taste or odour of a food. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
Drug Classes (2)
| Class | Description |
|---|---|
| triglyceride | Any glyceride resulting from the condensation of all three hydroxy groups of glycerol (propane-1,2,3-triol) with fatty acids. |
| propanoate ester | Any carboxylic ester where the carboxylic acid component is propionic acid. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
Research
Studies (12)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 29.24
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (29.24) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (8.33%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 11 (91.67%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||